Table VII.1

Table VII.1: How States Rated the Usefulness of Information on FDA’s Website Related to Drug Compounding, by Number of Reporting States
	Level of usefulness (number of states)
Information on the Food and Drug Administration’s (FDA) website	Very useful	Moderately useful	Slightly useful	Not at all useful	Have not used	No response
General information on drug compounding	9	25	9	0	6	1
Information related to section 503A of the Federal Food, Drug, and Cosmetic Act	13	21	9	1	5	1
Information related to section 503B of the Federal Food, Drug, and Cosmetic Act	13	23	8	0	5	1
Information on the federal Drug Quality and Security Act (Pub. L. No. 113-54)	10	23	10	1	5	1
Information on and time frames for FDA's plans for implementing the federal Drug Quality and Security Act (Pub. L. No. 113-54)	9	15	14	6	5	1
FDA proposed and final rules related to drug compounding	6	23	12	3	5	1
FDA guidance documents related to drug compounding	9	17	14	3	6	1

^{Source: GAO survey of state pharmacy regulatory bodies, survey question 46. | GAO-17-363SP}

Note: GAO surveyed the state pharmacy regulatory bodies in the 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands, and all but 4 completed the survey.